marijuana stocks news

Medbox, Inc. (MDBX)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 105   173   360   (9)
Cost of Revenue 305 1,814 729 950
Gross Profit (200) (1,640) (369) (959)
Operating Expenses
Research Development 106 62 67 8
Selling General and Administrative 6,110 2,277 950 705
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (6,415) (3,980) (1,386) (1,672)
Income from Continuing Operations
Total Other Income/Expenses Net (2,354) 497 38 14
Earnings Before Interest And Taxes (9,738) (3,797) (1,348) (1,658)
Interest Expense
Income Before Tax (9,738) (3,797) (1,348) (1,658)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (9,738) (3,797) (1,348) (1,658)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (9,738) (3,797) (1,348) (1,658)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (9,738) (3,797) (1,348) (1,658)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

CLS Holdings USA, Inc. (CLSH) Reports Momentous September Results

CLS Holdings USA, Inc. Reports Momentous September Results, Starting Second Fiscal Quarter…

$PLPL $20 Million Operation at Senteeko Tea Estate

New Video Documents Plandai Biotechnology’s $20 Million Operation at Senteeko Tea Estate…

$CARA to Present at the 2015 International Conference on Opioids

Cara Therapeutics to Present at the 2015 International Conference on Opioids  Cara…

Cara Therapeutics, Inc. (CARA) to Announce Fourth Quarter and Full Year 2019 Financial Results

Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results…